Market Definition
Proteins are complex molecular commodities produced from biological processes, where each has different parameters like size, molecular structure, and physicochemical properties, among others. Due to these differences, several pharmaceutical & biotechnological companies, academic research institutes, and CROs (Contract Research Organizations), among others, are inclining toward protein characterization & identification.
Protein characterization uses experimental methods for the detection & isolation of protein, characterizing its role in the safety & efficacy determination of different biological products. It also enables developers to enhance accuracy, specificity, & sensitivity while strengthening protein assays & developing new ones to target precise areas of concern.
On the other hand, Protein Identification determines the process of identifying the biological & cellular samples of the protein content through interrogation using mass spectrometry. The step is essential in studying protein characterization and gaining popularity among end-users.
Market Insights
The Global Protein Characterization and Identification Market is projected to grow at a CAGR of around 13.4% during the forecast period, i.e., 2022-27. The growth of the market would be driven primarily by the growing population suffering from chronic diseases and the mounting focus of governments of different countries on strengthening their healthcare industries & developing new therapeutics to cater to the patient influx worldwide. It, in turn, is surging the demand for protein characterization & identification methods to analyze the cellular dynamics & bring developments in treatments.
Besides, growing acceptance for personalized medicine among patients, coupled with rapid technological advancements owing to a rise in drug discovery & developments, are also positively influencing the market growth. Moreover, the growing inclination of different countries on numerous research & development activities being conducted by several countries worldwide and their substantial investments in the industry are other notable aspects projecting an upward growth trend for the market in the coming years.
| Report Coverage | Details |
|---|---|
| Study Period | Historical Data: 2017-20 |
| Base Year: 2021 | |
| Forecast Period: 2022-27 | |
| CAGR (2022-2027) | 13.4% |
| Regions Covered | North America: The US, Canada, Mexico |
| South America: Brazil, Rest of South America | |
| Europe: Germany, The UK, France, Spain, Italy, Rest of Europe | |
| Asia-Pacific: China, Japan, India, Australia, Rest of Asia Pacific | |
| Middle East & Africa: GCC, South Africa, Rest of Middle East and Africa | |
| Key Companies Profiled | Advion, Inc., Agilent Technologies, Analytik Jena, Creative Proteomics, Cleaver Scientific, Danaher Corporation, HORIBA Ltd., JEOL Ltd., MassTech Inc., Merck KGaA, MS Bioworks, Promega Corporation, QIAGEN N.V., Rigaku Corporation, Sartorius AG, SERVA Electrophoresis GmbH, Thermo Fisher Scientific, VProteomics, and Waters Corporation. |
| Unit Denominations | USD Million/Billion |
Furthermore, since the outcomes from novel therapeutics have shown positive results on patients, researchers & developers are motivated to introduce innovations and cater to the high unmet needs of patients worldwide, which would further boost the global protein characterization and identification market through 2027.
Impact of Covid-19 on the Global Protein Characterization and Identification Market
With the advent of Covid-19 in 2020, the entire healthcare sector underwent significant disruptions & immense pressure to cater to the needs of the flooding patient pool globally. However, the effects of the pandemic were minimal on the Global Protein Characterization & Identification Market.
While the governments of different countries imposed stringent movement restrictions & lockdowns to curb the disease spread, several prominent players showed a greater inclination toward research & development activities on protein to learn more about its characterization & identification in order to develop therapeutics & preventive strategies for SARS-CoV-2 causing the Covid-19 virus.
Besides, there was a proliferation in demand for protein characterization & identification technology to understand & study the spike of the coronavirus for the development of synthetic vaccines. Hence, there was a considerable expansion in the market size amidst the crisis, which, in turn, presented a path for the leading companies in the industry to witness lucrative prospects in the coming years.
.png)